NewGen Announces Pricing of $1.25 Million Public Offering
Key Highlights
- ➤$1.25 million public offering priced for NewGenIvf Group (NIVF)
- ➤17,857,143 ordinary shares or pre-funded warrants offered
- ➤Offering priced at $0.07 per ordinary share
- ➤Proceeds target K25.ai investment, debt restructuring, and Nodexus deployment
- ➤Transaction expected to close September 30, 2026
BANGKOK, Sept. 29, 2026 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (the “Company”), a tech-forward, diversified, multi-jurisdictional high-growth entity transforming industries through innovative solutions across real estate development, digital asset management and reproductive health solutions, today announced the pricing of a public offering made on a reasonable best efforts basis with gross proceeds to the Company expected to be approximately $1.25 million, before deducting placement agent fees and other offering expenses payable by the Company.
The offering consists of 17,857,143 Ordinary Shares or Pre-Funded Warrants in lieu thereof. The public offering price per Common Share is $0.07 (or $0.06999 for each Pre-Funded Warrant, which is equal to the public offering price per Ordinary Share to be sold in the offering minus an exercise price of $0.00001 per Pre-Funded Warrant). The Pre-Funded Warrants will be immediately exercisable and may be exercised at any time until exercised in full. For each Pre-Funded Warrant sold in the offering, the number of Ordinary Shares in the offering will be decreased on a one-for-one basis.
Get started
Create a free account to read the full story.
